FDA — authorised 29 July 1974
- Application: NDA017431
- Marketing authorisation holder: EPIC PHARMA LLC
- Local brand name: OCUSERT PILO-20
- Indication: INSERT, EXTENDED RELEASE — OPHTHALMIC
- Status: approved
FDA authorised Artificial Saliva on 29 July 1974
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 29 July 1974; FDA has authorised it.
EPIC PHARMA LLC holds the US marketing authorisation.